Published in Vaccine Weekly, September 1st, 2004
Efforts to develop a vaccine to prevent group A streptococcal infections have been ongoing for more than 70 years. Recent advances have allowed previous obstacles associated with group A streptococcal vaccine development to be overcome. Group A streptococcal infections and their sequelae represent a global health problem.
Karen L. Kotloff, MD, of the University of Maryland School of Medicine, Baltimore, and colleagues reported on a preliminary study evaluating the safety...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly